Edwards Lifesciences

Medical Equipment
EW
$ 86 (0.79)%
Share price
$ 52 bn
Market Cap
$ 51 bn
Enterprise Value

Carbon footprint

0.9 Ton
GHG emissions per $ 1 mln investment
0.03x the weighted average for S&P 500
FY2020
How is this calculated?
+11%
YOY change in GHG emissions
Weaker than the -11% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

but has a science based goal that does not target absolute reductions but is still aligned with Paris Agreement according to SBTi

GHG emissions and Carbon intensity

Edwards Lifesciences's GHG emissions (market-based) (Kt of CO2e)
Edwards Lifesciences's Carbon intensity (Tons per 1 USDm)

Edwards Lifesciences's carbon footprint

Edwards Lifesciences reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 46 Kt (+4.4/+11% y-o-y). Carbon intensity also was up at 11 t (+0.9/+9.4% y-o-y).

Edwards Lifesciences's Scope 3 emissions plummeted to 31 Kt (-20 /-39.4% y-o-y). The time series has been volatile over the last few periods.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Edwards Lifesciences also has a science-based goal that, however, does not appear to explicitly target a company-wide reduction in emissions in absolute terms. Edwards Lifesciences commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year. Edwards Lifesciences also commits to reduce scope 3 GHG emissions 51.6% per USD of value added within the same timeframe.

Company environmental metrics

Show more...